223 related articles for article (PubMed ID: 24285772)
1. Surrogacy assessment using principal stratification when surrogate and outcome measures are multivariate normal.
Conlon AS; Taylor JM; Elliott MR
Biostatistics; 2014 Apr; 15(2):266-83. PubMed ID: 24285772
[TBL] [Abstract][Full Text] [Related]
2. Surrogacy assessment using principal stratification and a Gaussian copula model.
Conlon A; Taylor J; Elliott MR
Stat Methods Med Res; 2017 Feb; 26(1):88-107. PubMed ID: 24947559
[TBL] [Abstract][Full Text] [Related]
3. Surrogacy assessment using principal stratification with multivariate normal and Gaussian copula models.
Taylor JM; Conlon AS; Elliott MR
Clin Trials; 2015 Aug; 12(4):317-22. PubMed ID: 25490988
[TBL] [Abstract][Full Text] [Related]
4. A bayesian approach to surrogacy assessment using principal stratification in clinical trials.
Li Y; Taylor JM; Elliott MR
Biometrics; 2010 Jun; 66(2):523-31. PubMed ID: 19673864
[TBL] [Abstract][Full Text] [Related]
5. Solutions for surrogacy validation with longitudinal outcomes for a gene therapy.
Roberts EK; Elliott MR; Taylor JMG
Biometrics; 2023 Sep; 79(3):1840-1852. PubMed ID: 35833874
[TBL] [Abstract][Full Text] [Related]
6. Accommodating missingness when assessing surrogacy via principal stratification.
Elliott MR; Li Y; Taylor JM
Clin Trials; 2013; 10(3):363-77. PubMed ID: 23553326
[TBL] [Abstract][Full Text] [Related]
7. Causal assessment of surrogacy in a meta-analysis of colorectal cancer trials.
Li Y; Taylor JM; Elliott MR; Sargent DJ
Biostatistics; 2011 Jul; 12(3):478-92. PubMed ID: 21252079
[TBL] [Abstract][Full Text] [Related]
8. Incorporating baseline covariates to validate surrogate endpoints with a constant biomarker under control arm.
Roberts EK; Elliott MR; Taylor JMG
Stat Med; 2021 Dec; 40(29):6605-6618. PubMed ID: 34528260
[TBL] [Abstract][Full Text] [Related]
9. A new proportion measure of the treatment effect captured by candidate surrogate endpoints.
Kobayashi F; Kuroki M
Stat Med; 2014 Aug; 33(19):3338-53. PubMed ID: 24782344
[TBL] [Abstract][Full Text] [Related]
10. Validation of surrogate endpoints in cancer clinical trials via principal stratification with an application to a prostate cancer trial.
Tanaka S; Matsuyama Y; Ohashi Y
Stat Med; 2017 Aug; 36(19):2963-2977. PubMed ID: 28485043
[TBL] [Abstract][Full Text] [Related]
11. Links between causal effects and causal association for surrogacy evaluation in a gaussian setting.
Conlon A; Taylor J; Li Y; Diaz-Ordaz K; Elliott M
Stat Med; 2017 Nov; 36(27):4243-4265. PubMed ID: 28786131
[TBL] [Abstract][Full Text] [Related]
12. Evaluating candidate principal surrogate endpoints.
Gilbert PB; Hudgens MG
Biometrics; 2008 Dec; 64(4):1146-54. PubMed ID: 18363776
[TBL] [Abstract][Full Text] [Related]
13. A maximum entropy approach for the evaluation of surrogate endpoints based on causal inference.
Alonso A; Van der Elst W; Molenberghs G
Stat Med; 2018 Dec; 37(29):4525-4538. PubMed ID: 30141219
[TBL] [Abstract][Full Text] [Related]
14. A reflection on the causal interpretation of individual-level surrogacy.
Alonso A; Van Der Elst W; Molenberghs G; Florez AJ
J Biopharm Stat; 2019; 29(3):529-540. PubMed ID: 30773114
[TBL] [Abstract][Full Text] [Related]
15. On the relationship between association and surrogacy when both the surrogate and true endpoint are binary outcomes.
Meyvisch P; Alonso A; Van der Elst W; Molenberghs G
Stat Med; 2020 Nov; 39(26):3867-3878. PubMed ID: 32875590
[TBL] [Abstract][Full Text] [Related]
16. Bayesian adjusted R2 for the meta-analytic evaluation of surrogate time-to-event endpoints in clinical trials.
Renfro LA; Shi Q; Sargent DJ; Carlin BP
Stat Med; 2012 Apr; 31(8):743-61. PubMed ID: 22161275
[TBL] [Abstract][Full Text] [Related]
17. On assessing surrogacy in a single trial setting using a semicompeting risks paradigm.
Ghosh D
Biometrics; 2009 Jun; 65(2):521-9. PubMed ID: 18759839
[TBL] [Abstract][Full Text] [Related]
18. Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacy.
Gabriel EE; Gilbert PB
Biostatistics; 2014 Apr; 15(2):251-65. PubMed ID: 24337534
[TBL] [Abstract][Full Text] [Related]
19. An information-theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation.
Alonso Abad A; Ong F; Stijven F; Van der Elst W; Molenberghs G; Van Keilegom I; Verbeke G; Callegaro A
Stat Med; 2024 Mar; 43(6):1083-1102. PubMed ID: 38164018
[TBL] [Abstract][Full Text] [Related]
20. An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference.
Alonso A; Van der Elst W; Molenberghs G; Buyse M; Burzykowski T
Biometrics; 2016 Sep; 72(3):669-77. PubMed ID: 26864244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
